These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 34558984)

  • 41. Failure to Respond after Reinstatement of Antidepressant Medication: A Systematic Review.
    Bosman RC; Waumans RC; Jacobs GE; Oude Voshaar RC; Muntingh ADT; Batelaan NM; van Balkom AJLM
    Psychother Psychosom; 2018; 87(5):268-275. PubMed ID: 30041180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does anti-obsessional pharmacotherapy treat so-called comorbid depressive and anxiety states?
    Valerio C; Diniz JB; Fossaluza V; de Mathis MA; Belotto-Silva C; Joaquim MA; Miguel Filho EC; Shavitt RG
    J Affect Disord; 2012 Jul; 139(2):187-92. PubMed ID: 22455835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tricyclic drugs for depression in children and adolescents.
    Hazell P; Mirzaie M
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD002317. PubMed ID: 23780719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults.
    Skapinakis P; Caldwell D; Hollingworth W; Bryden P; Fineberg N; Salkovskis P; Welton N; Baxter H; Kessler D; Churchill R; Lewis G
    Health Technol Assess; 2016 Jun; 20(43):1-392. PubMed ID: 27306503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis.
    Nelson JC; Delucchi K; Schneider LS
    Int J Geriatr Psychiatry; 2009 May; 24(5):539-44. PubMed ID: 19334041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and Meta-analysis.
    van Dis EAM; van Veen SC; Hagenaars MA; Batelaan NM; Bockting CLH; van den Heuvel RM; Cuijpers P; Engelhard IM
    JAMA Psychiatry; 2020 Mar; 77(3):265-273. PubMed ID: 31758858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
    Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-Term Outcome of Pediatric Obsessive-Compulsive Disorder: A Meta-Analysis.
    Liu J; Cui Y; Yu L; Wen F; Wang F; Yan J; Yan C; Li Y
    J Child Adolesc Psychopharmacol; 2021 Mar; 31(2):95-101. PubMed ID: 33395547
    [No Abstract]   [Full Text] [Related]  

  • 49. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
    Feusner JD; Kerwin L; Saxena S; Bystritsky A
    Psychopharmacol Bull; 2009; 42(1):81-93. PubMed ID: 19204653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Psychedelics in the treatment of depression, anxiety, and obsessive-compulsive disorder].
    Breeksema JJ; van den Brink W; Veraart JKE; Smith-Apeldoorn SY; Vermetten E; Schoevers RA
    Tijdschr Psychiatr; 2020; 62(8):618-628. PubMed ID: 32816290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lesional psychiatric neurosurgery: meta-analysis of clinical outcomes using a transdiagnostic approach.
    Davidson B; Eapen-John D; Mithani K; Rabin JS; Meng Y; Cao X; Pople CB; Giacobbe P; Hamani C; Lipsman N
    J Neurol Neurosurg Psychiatry; 2022 Feb; 93(2):207-215. PubMed ID: 34261748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A transdiagnostic systematic review and meta-analysis of ketamine's anxiolytic effects.
    Hartland H; Mahdavi K; Jelen LA; Strawbridge R; Young AH; Alexander L
    J Psychopharmacol; 2023 Aug; 37(8):764-774. PubMed ID: 37005739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders.
    Whittaker E; Dadabayev AR; Joshi SA; Glue P
    Ther Adv Psychopharmacol; 2021; 11():20451253211056743. PubMed ID: 34925757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional Neuroimaging Correlates of Placebo Response in Patients With Depressive or Anxiety Disorders: A Systematic Review.
    Huneke NTM; Aslan IH; Fagan H; Phillips N; Tanna R; Cortese S; Garner M; Baldwin DS
    Int J Neuropsychopharmacol; 2022 Jun; 25(6):433-447. PubMed ID: 35078210
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diverse predictors of treatment response to active medication and placebo in gambling disorder.
    Huneke NTM; Chamberlain SR; Baldwin DS; Grant JE
    J Psychiatr Res; 2021 Dec; 144():96-101. PubMed ID: 34607088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Raising Placebo Efficacy in Antidepressant Trials Across Decades Explained by Small-Study Effects: A Meta-Reanalysis.
    Holper L
    Front Psychiatry; 2020; 11():633. PubMed ID: 32848900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Effects of Dietary Improvement on Symptoms of Depression and Anxiety: A Meta-Analysis of Randomized Controlled Trials: Erratum.
    Psychosom Med; 2020 Jun; 82(5):536. PubMed ID: 32310838
    [No Abstract]   [Full Text] [Related]  

  • 58. Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-analysis.
    Jones BDM; Razza LB; Weissman CR; Karbi J; Vine T; Mulsant LS; Brunoni AR; Husain MI; Mulsant BH; Blumberger DM; Daskalakis ZJ
    JAMA Netw Open; 2021 Sep; 4(9):e2125531. PubMed ID: 34559231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A nationwide nested case-control study of new-onset obsessive-compulsive disorder following antipsychotics use in schizophrenia.
    Park CI; Han M; Jung I; Kim EH; Kang JI; Kim SJ
    Acta Psychiatr Scand; 2021 Dec; 144(6):589-598. PubMed ID: 34564841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents.
    Correll CU; Solmi M; Cortese S; Fava M; Højlund M; Kraemer HC; McIntyre RS; Pine DS; Schneider LS; Kane JM
    World Psychiatry; 2023 Feb; 22(1):48-74. PubMed ID: 36640403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.